Harpreet Singh Bhatia MD MAS FACC
Assistant Professor of Medicine at UC San Diego
Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 800-926-8273
Fax+1 888-539-8781
Dr. Bhatia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California, San DiegoPost-Doctoral Fellowship, 2020 - 2022
University of California at San DiegoMAS, Clinical Research, 2020 - 2022
University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 2018 - 2021
New York Presbyterian Hospital (Cornell Campus)Chief Residency, Internal Medicine, 2017 - 2018- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2014 - 2017
Emory University School of MedicineClass of 2014
Certifications & Licensure
CA State Medical License 2018 - 2025
NY State Medical License 2017 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Lipoprotein(a), high-sensitivity c-reactive protein, homocysteine and cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.Sarah O Nomura, Harpreet S Bhatia, Parveen K Garg, Amy B Karger, Weihua Guan
American Journal of Preventive Cardiology. 2025-03-01 - Polygenic risk, aspirin, and primary prevention of coronary artery disease.Chenglong Yu, Pradeep Natarajan, Aniruddh P Patel, Harpreet S Bhatia, Amit V Khera
European Heart Journal. Cardiovascular Pharmacotherapy. 2025-02-08 - 2 citationsIndependence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.Harpreet S Bhatia, Simon Wandel, Peter Willeit, Anastasia Lesogor, Keith Bailey
Circulation. 2025-01-28
Press Mentions
205. Guidelines: 2021 ESC Cardiovascular Prevention – Question #11 with Dr. Eugenia GianosMay 12th, 2022
Meth-Related Heart Failure Worse, but Responds Well to Meds if Abuse StopsNovember 21st, 2019
Meth Cessation May Reverse Drug-Induced HFNovember 20th, 2019- Join now to see all
Grant Support
- Aspirin for Primary Prevention of Cardiovascular Disease in Patients with Elevated Lipoprotein(a)UNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
